Is a complete AVIR research report available?

No complete published report is available for Atea Pharmaceuticals, Inc. (AVIR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ: AVIR · USD

$4.22

+0.05 (+1.2%)· Recorded snapshot

Market cap	338.5M
Net income (ttm)	-165.3M
EPS (ttm)	-$2.10
Shares out	80.2M
Volume	267,156
Beta	0.39

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -165.3M
EPS (ttm): -$2.10
Market cap: 338.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001593899
Company name	Atea Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	04683R106
Earnings date	2026-11-11
Earnings time	amc
Employees	55
Employees change	-1
Employees growth	-1.79%
Enterprise value	$119.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-10-30
Is primary listing	Yes
Is SPAC	No
ISIN number	US04683R1068
Last 10-K release date	2026-03-05
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$338.5M
Market cap category	Small-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$4.22
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	AVIR
U.S. state	Massachusetts
Website	https://ateapharma.com

Metric

Value

Amount currency

USD

CIK code

0001593899

Company name

Atea Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

04683R106

Earnings date

2026-11-11

Earnings time

amc

Employees

Employees change

-1

Employees growth

-1.79%

Enterprise value

$119.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2012

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2020-10-30

Is primary listing

Yes

Is SPAC

ISIN number

US04683R1068

Last 10-K release date

2026-03-05

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$338.5M

Market cap category

Small-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$4.22

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

AVIR

U.S. state

Massachusetts

Website

https://ateapharma.com

Metric	Value
Earnings yield	-49.67%
FCF / EV yield	-128.2%
FCF yield	-45.04%
P/B ratio	1.64x
Price / tangible book value	1.65x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-49.67%

FCF / EV yield

-128.2%

FCF yield

-45.04%

P/B ratio

1.64x

Price / tangible book value

1.65x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-3M
ROA	-36.72%
ROA (5Y)	-11.07%
ROCE	-89.77%
ROE	-58.14%
ROE (5Y)	-19.77%
ROIC	-40.17%

Metric

Value

Profit per employee

$-3M

ROA

-36.72%

ROA (5Y)

-11.07%

ROCE

-89.77%

ROE

-58.14%

ROE (5Y)

-19.77%

ROIC

-40.17%

Metric	Value
EPS growth quarters	1
EPS growth years	1
Net income growth quarters	1
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$416,000
EBIT	$-183.3M
EBITDA	$-182.9M
EPS	$-2.10
FCF per share	$-1.90
Financing cash flow	$-11M
Free cash flow	$-152.1M
Free cash flow minus SBC	$-168.3M
Gross profit	$-155.1M
Income taxes	$-6.5M
Investing cash flow	$151.9M
Net cash flow	$-11.2M
Net income	$-165.3M
Operating cash flow minus SBC	$-168.3M
Operating income	$-183.3M
Stock-based compensation	$16.2M

Metric

Value

Depreciation and amortization

$416,000

EBIT

$-183.3M

EBITDA

$-182.9M

EPS

$-2.10

FCF per share

$-1.90

Financing cash flow

$-11M

Free cash flow

$-152.1M

Free cash flow minus SBC

$-168.3M

Gross profit

$-155.1M

Income taxes

$-6.5M

Investing cash flow

$151.9M

Net cash flow

$-11.2M

Net income

$-165.3M

Operating cash flow minus SBC

$-168.3M

Operating income

$-183.3M

Stock-based compensation

$16.2M

Metric	Value
Book value per share	$2.55
Debt / equity	0
Long-term assets	$3.6M
Long-term liabilities	$0
Net cash (debt)	$219M
Net cash / market cap	64.87%
Net cash growth	-42.12%
Net debt / equity	-1.07
Piotroski F-Score	1
Property, plant and equipment	$569,000
Shareholders' equity	$204.2M
Tangible book value	$204.2M
Tangible book value per share	$2.55
Total assets	$232.3M
Total cash	$219.5M
Total debt	$424,000
Total liabilities	$28.1M
WACC	6.38%

Metric

Value

Book value per share

$2.55

Debt / equity

Long-term assets

$3.6M

Long-term liabilities

Net cash (debt)

$219M

Net cash / market cap

64.87%

Net cash growth

-42.12%

Net debt / equity

-1.07

Piotroski F-Score

Property, plant and equipment

$569,000

Shareholders' equity

$204.2M

Tangible book value

$204.2M

Tangible book value per share

$2.55

Total assets

$232.3M

Total cash

$219.5M

Total debt

$424,000

Total liabilities

$28.1M

WACC

6.38%

Metric	Value
Current assets	$228.7M
Current liabilities	$28.1M
Current ratio	8.13
Net working capital	$-18.5M
Quick ratio	7.8
Working capital	$200.5M

Metric

Value

Current assets

$228.7M

Current liabilities

$28.1M

Current ratio

8.13

Net working capital

$-18.5M

Quick ratio

7.8

Working capital

$200.5M

Metric	Value
Buyback yield / dilution	6.62%
Dividend yield	0%
Shareholder yield	6.62%

Metric

Value

Buyback yield / dilution

6.62%

Dividend yield

Shareholder yield

6.62%

Metric	Value
150-day SMA	$5.00
1D price change	1.2%
1M price change	-18.76%
1M total return	-18.76%
1W price change	-5.94%
1W total return	-5.94%
1Y price change	29.23%
1Y return CAGR	29.25%
1Y total return	29.23%
20-day SMA	$4.64
200-day SMA	$4.92
3M price change	-12.86%
3M total return	-12.86%
3Y price change	36.36%
3Y return CAGR	10.89%
3Y total return	36.36%
50-day SMA	$5.09
50-day SMA vs 200-day SMA	50over200
52-week high	$6.45
52-week high date	2026-03-10
52-week low	$2.87
52-week low date	2025-11-13
5Y price change	-65.49%
5Y return CAGR	-19.17%
5Y total return	-65.49%
6M price change	-21.64%
6M total return	-21.64%
All-time high	$94.17
All-time high date	2021-02-11
All-time low	$2.46
All-time low date	2025-05-15
Average true range (ATR)	$0.23
Average volume	296.6K
Beta (1Y)	1.19
Beta (2Y)	0.65
Beta (5Y)	0.39
Change from 52-week high	-34.57%
Change from 52-week low	47.04%
Change from all-time high	-95.54%
Change from all-time low	71.08%
Change from open	1.2%
Day's gap	0%
Dollar volume	$1.1M
High price	$4.24
Low price	$4.15
Monthly RSI	47.65
Open price	$4.17
Position in 52-week range	82.35%
Premarket change	0.97%
Premarket close	$4.17
Premarket price	$4.21
Previous close	$4.17
Price vs 150-day SMA	-15.95%
Price vs 20-day SMA	-9.48%
Price vs 200-day SMA	-14.65%
Price vs 50-day SMA	-17.53%
Relative volume	0.9
Return from IPO open	-84.42%
Return from IPO price	-82.46%
RSI	32.18
Sharpe ratio	0.68
Sharpe ratio (3Y)	0.41
Sharpe ratio (5Y)	-0.23
Sortino ratio	1.07
Sortino ratio (3Y)	0.72
Sortino ratio (5Y)	-0.23
Volume	267.2K
Weekly RSI	41.35
YTD price change	17.65%
YTD total return	17.65%

Metric

Value

150-day SMA

$5.00

1D price change

1.2%

1M price change

-18.76%

1M total return

-18.76%

1W price change

-5.94%

1W total return

-5.94%

1Y price change

29.23%

1Y return CAGR

29.25%

1Y total return

29.23%

20-day SMA

$4.64

200-day SMA

$4.92

3M price change

-12.86%

3M total return

-12.86%

3Y price change

36.36%

3Y return CAGR

10.89%

3Y total return

36.36%

50-day SMA

$5.09

50-day SMA vs 200-day SMA

50over200

52-week high

$6.45

52-week high date

2026-03-10

52-week low

$2.87

52-week low date

2025-11-13

5Y price change

-65.49%

5Y return CAGR

-19.17%

5Y total return

-65.49%

6M price change

-21.64%

6M total return

-21.64%

All-time high

$94.17

All-time high date

2021-02-11

All-time low

$2.46

All-time low date

2025-05-15

Average true range (ATR)

$0.23

Average volume

296.6K

Beta (1Y)

1.19

Beta (2Y)

0.65

Beta (5Y)

0.39

Change from 52-week high

-34.57%

Change from 52-week low

47.04%

Change from all-time high

-95.54%

Change from all-time low

71.08%

Change from open

1.2%

Day's gap

Dollar volume

$1.1M

High price

$4.24

Low price

$4.15

Monthly RSI

47.65

Open price

$4.17

Position in 52-week range

82.35%

Premarket change

0.97%

Premarket close

$4.17

Premarket price

$4.21

Previous close

$4.17

Price vs 150-day SMA

-15.95%

Price vs 20-day SMA

-9.48%

Price vs 200-day SMA

-14.65%

Price vs 50-day SMA

-17.53%

Relative volume

0.9

Return from IPO open

-84.42%

Return from IPO price

-82.46%

RSI

32.18

Sharpe ratio

0.68

Sharpe ratio (3Y)

0.41

Sharpe ratio (5Y)

-0.23

Sortino ratio

1.07

Sortino ratio (3Y)

0.72

Sortino ratio (5Y)

-0.23

Volume

267.2K

Weekly RSI

41.35

YTD price change

17.65%

YTD total return

17.65%

Metric	Value
Float	60.3M
Float percentage	75.23%
Shares change (QoQ)	1.08%
Shares change (YoY)	-6.62%
Shares held by insiders	16.1%
Shares held by institutions	67.87%
Shares outstanding	80.2M
Short % of float	5.09%
Short % of shares	3.83%
Short ratio	27 days

Metric

Value

Float

60.3M

Float percentage

75.23%

Shares change (QoQ)

1.08%

Shares change (YoY)

-6.62%

Shares held by insiders

16.1%

Shares held by institutions

67.87%

Shares outstanding

80.2M

Short % of float

5.09%

Short % of shares

3.83%

Short ratio

27 days

Atea Pharmaceuticals, Inc. (AVIR)

Price

Financial snapshot

Fair-value bridge

Latest news · AVIR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AVIR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AVIR

Frequently asked questions